bioRxivCancer Biology
Cell-type specific expression of oncogenic and tumor suppressive microRNAs in the human prostate and prostate cancer
B. Kumar, A. Z. Rosenberg, S. M. Choi, K. Fox-Talbot, A. M. De Marzo, L. Nonn, W. N. Brennen, L. Marchionni, M. K. Halushka, S. E. Lupold
Abstract
MiR-1 and miR-143 are frequently reduced in human prostate cancer (PCa), while miR-141 and miR-21 are frequently elevated. Consequently, these miRNAs have been studied as cell-autonomous tumor suppressors and oncogenes. However, the cell-type specificity of these miRNAs is not well defined in prostate tissue. Through two different microdissection techniques, and droplet digital RT-PCR, we quantified these miRNAs in the stroma and epithelium of radical prostatectomy specimens. In contrast to their purported roles as cell-autonomous tumor suppressors, we found miR-1 and miR-143 expression to be predominantly stromal. Conversely, miR-141 was predominantly epithelial. MiR-21 was detected in both stroma and epithelium. Strikingly, the levels of miR-1 and miR-143 were significantly reduced in tumor-associated stroma, but not tumor epithelium. Gene expression analyses in human cell lines, tissues, and prostate-derived stromal cultures support the cell-type selective expression of miR-1, miR-141, and miR-143. Analyses of the PCa Genome Atlas (TCGA-PRAD) showed a strong positive correlation between stromal markers and miR-1 and miR-143, and a strong negative correlation between stromal markers and miR-141. In these tumors, loss of miR-1 and gain of miR-21 was highly associated with biochemical recurrence. These data shed new light on stromal and epithelial miRNA expression in the PCa tumor microenvironment.
- organism: human
- assay: bulk RNA-seq
- research focus: differential expression
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Cell Type-Specific Effects of miR-21 Loss Attenuate Tumor Progression in MYC-Driven Prostate Cancer
Kenji Zennami, Mindy Kim Graham, … Shawn E. Lupold·bioRxiv·May 14, 2025
- MicroRNA-194 promotes lineage plasticity in advanced prostate cancer
R. C. Fernandes, J. Toubia, … L. Selth·bioRxiv·Sep 12, 2019
- miR-100-5p downregulates mTOR to suppress the proliferation, migration and invasion of prostate cancer cells
s. li, Y. Ye, J.-j. Wang·bioRxiv·Jul 30, 2020
- Intracellular interaction of FNDC1/FN1/AR/cMYC in prostate cancer cells
P. Ghosh, O. Ogunwobi·bioRxiv·Feb 23, 2023
- The miR-96 and RAR&gamma signaling axis governs androgen signaling and prostate cancer progression
M. D. Long, P. K. Singh, … M. J. Campbell·bioRxiv·Apr 26, 2018
- MIRO2 regulates prostate cancer cell growth via GCN1-dependent stress signaling
M. Furnish, D. P. Boulton, … M. C. Caino·bioRxiv·May 20, 2021